Urinary Tract Infection (UTI) Treatment Market
Market Insights on Urinary Tract Infection (UTI) Treatment covering sales outlook, demand forecast & up-to-date key trends
Urinary Tract Infection (UTI) Treatment Market By Drug Class (Penicillin & Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides) Indication (Complicated Urinary Tract Infection), Distribution Channel (Hospital Pharmacies, Gynecology and Urology Clinics) & Region - Forecast 2019 - 2029
Urinary Tract Infection (UTI) Treatment Market – Key Research Findings
- Urinary tract infection treatment market size valuated in 2018 was ~US$ 10 Bn.
- The UTI treatment market is anticipated to grow at a CAGR of ~2% over 2019-2029.
- Europe is expected to remain the leading regional market for urinary tract infection treatment.
- Leading companies operating in the UTI treatment market are focusing on expanding production facilities and establishing long-term distribution contracts with major local distribution companies, to stay competitive among their peers in the urinary tract infection market.
- Quinolones, in terms of drug class, are projected to lead the way in urinary tract infection treatment market over the forecast period.
Customize this Report
Let us know your requirement to get
100% FREE customization
Top 3 Factors Shaping the Urinary Tract Infection Treatment Market
-
Increasing UTI Prevalence to Drive the Urinary Tract Infection Treatment Market
Urinary tract infection is more common in women compared to men due to their anatomy. Several women experience urinary tract infection more than once in their lifetime. According to certain studies, urinary tract infection affects approximately 150 million people globally. In addition, approximately 11% women visit one physician in a year for urinary tract infection treatment.
Hormonal changes, improper personal hygiene, use of catheters, and other factors are some of the main causes of urinary tract infection. With an increase in the prevalence of urinary tract infection, the urinary tract infection treatment market is expected to witness significant growth in the coming years.
-
Rising Demand for Antibiotics to Contribute to the Demand for Urinary Tract Infection Treatment
Antibiotics are the only treatment options available for urinary tract infection. According to the severity of the infection, a wide range of antibiotics are prescribed. For instance, for uncomplicated urinary tract infection treatment, fluoroquinolones, trimethoprim/sulfamethoxazole, and aminoglycosides are prescribed as initial treatment.
Similarly, for complicated urinary tract infection treatment cases, fluoroquinolones such as ciprofloxacin or ofloxacin are prescribed in case of less severe infection. Apart from these, loss of patent rights of branded drugs and the availability of cost-effective antibiotics from generic companies are among factors that are likely to spur the growth of the urinary tract infection treatment market.
-
Rising Use of Urinary Catheters and Other Drainage Devices Likely to Offer an Uptick to Urinary Tract Infection Treatment Market Growth
The rising incidence of chronic kidney diseases, such as bladder cancer and renal failure, has led to the increase usage of catheters and other drainage devices in patients. Patients using urinary catheters are more likely to acquire complicated UTI. According to World Health Organization (WHO), the risk of bacteriuria is approximately 5% per day for patients using urinary catheters and 40% suffer from nosocomial infections.
Certain factors, such as prolonged duration of catheterisation, not receiving system therapy of antibiotics, bacterial colonisation in drainage bags, rapid fata underlying diseases, and others, are likely to result in catheter-associated urinary tract infection. Hence, increase in the usage of urinary catheters will foster the growth of the urinary tract infection treatment market.
Urinary Tract Infection Treatment Market Structure Analysis
- Key comapnies spearheading the comeptition landscape of the global UTI treatment market, such as Bayer AG, are focused on stregthening their R&D activties for the development of novel drug molecules.
- FMI analyses that a majority of leading players, for instance Allergan Plc, in urinary tract infection treatment market are also prioritizing strategic collaborations and acquisitions to achieve broader availability on market and tap the unmet needs of patients.
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystUrinary Tract Infection Treatment: Antibiotics for the Management of Urinary Tract Infection
The Urinary Tract Infection (UTI) treatment market is anticipated to witness growth since antibiotics are the only treatment for the management of the same. Loss of patent rights by branded drugs and the emergence of branded generics and generic drugs are among factors that are likely to boost the urinary tract infection treatment market.
Market Set to Grow by 1.2X between 2019 and 2029
The urinary tract infection treatment market is expected to register considerable growth owing to the rising prevalence of urinary tract infections and increase in the number of hospital visits for urinary tract infection testing as well as treatment. Moreover, the high demand for antibiotics in urinary tract infection treatment and growth in the number of generic players is likely to propel the growth of the urinary tract infection treatment market.
Emerging Countries Foster New Growth Opportunities for the Urinary Tract Infection Treatment Market
Europe holds a prominent revenue share among other regions in the global urinary tract infection treatment market in 2019. However, developing countries, such as China, India, and South Korea, have witnessed growth in the urinary tract infection treatment market due to increasing awareness about urinary tract infection treatment and rising government initiatives for healthcare spending.
The Broader Perspective
Various manufacturers are engaged in strategic acquisitions and collaborations with different companies and distribution channels to increase the sales of their products and enhance their business operations.
How Growth will Unfold
The prevalence of UTI is increasing at an alarming rate. Improper use of disposable hygiene products for personal use, administration of catheters in urethra, sexual activity, menopause, and certain other factors are anticipated to boost the urinary tract infection treatment market. The growing demand for antibiotics and the low cost of generic drugs is also expected to spur the growth of the urinary tract infection treatment market.
Become a MarketNgage Insider
A unified Market Research Subscription Platform, built for today's disparate research needs.
UTI (URINARY TRACT INFECTION) TREATMENT MARKET TAXONOMY
The global urinary tract infection treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
By Drug Class
- Penicillin & Combinations
- Quinolones
- Cephalosporin
- Aminoglycoside Antibiotics
- Sulphonamides (Sulfamethoxazole, Trimethoprim)
- Azoles and Amphotericin B
- Tetracycline (Doxycycline)
- Nitrofurans (Nitrofurantoin)
- Others
By Indication
- Complicated Urinary Tract Infection
- Uncomplicated Urinary Tract Infection
By Distribution Channel
- Hospital Pharmacies
- Gynecology and Urology Clinics
- Drug Stores
- Retail Pharmacies
- Online Drug Stores
Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Frequently Asked Questions
How is the Urinary Tract Infections Market Growing?
The urinary tract infections market is predicted to grow at 2% CAGR through 2032.
Which Region Holds the Highest Revenue Potential in the Urinary Tract Infections Market?
Asia Pacific urinary tract infections market holds the highest revenue potential.
What is the Future Scope of Growth for the Urinary Tract Infections Market?
The urinary tract infections market is expected to surpass US$ 10.29 Bn by 2032.
What is the Current Urinary Tract Infections Market Size?
The urinary tract infections market size is anticipated to be over US$ 12.54 Bn in 2022.
Table of Content
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Global Urinary Tract Infection Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029 5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018 5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Market Background 6.1. Macro-Economic Factors 6.1.1. Favourable Incentive & Reimbursement Policies 6.1.2. Increasing Consumption of Antibiotics per Capita 6.2. Forecast Factors - Relevance & Impact 6.2.1. Increase in Drug Resistance 6.2.2. Patent Loss of Branded Drugs 6.2.3. Government Regulations in Product Approval 6.3. Market Dynamics 6.3.1. Drivers 6.3.2. Restraints 6.3.3. Opportunity Analysis 7. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2014 - 2018 7.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Drug Class, 2019 - 2029 7.3.1. Penicillin and Combinations 7.3.1.1. Amoxicillin 7.3.1.2. Amoxicillin and Clavulanate Potassium 7.3.1.3. Others 7.3.2. Quinolones 7.3.2.1. Ciprofloxaxin 7.3.2.2. Levofloxaxin 7.3.2.3. Nalidixic acid 7.3.2.4. Norfloxacin 7.3.2.5. Others 7.3.3. Cephalosporin 7.3.3.1. Ceftriaxone 7.3.3.2. Cefuroxime 7.3.3.3. Cefixime 7.3.3.4. Cephalexin 7.3.4. Aminoglycoside Antibiotics 7.3.4.1. Amikacin 7.3.4.2. Gentamicin 7.3.5. Sulphonamides (Sulfamethoxazole +Trimethoprim) 7.3.6. Azoles and Amphotericin B 7.3.7. Tetracycline (Doxycycline) 7.3.8. Nirtofurans (Nitrofurantoin) 7.3.9. Other 7.4. Market Attractiveness Analysis By Drug Class 8. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Indication 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) and Analysis By Indication, 2014 - 2018 8.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Indication, 2019- 2029 8.3.1. Complicated Urinary Tract Infection 8.3.2. Uncomplicated Urinary Tract Infection 8.4. Market Attractiveness Analysis By Indication 9. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) and Analysis By Distribution Channel, 2014 - 2018 9.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Distribution Channel, 2019 - 2029 9.3.1. Hospital Pharmacies 9.3.2. Gynaecology and Urology Clinics 9.3.3. Drug Stores 9.3.4. Retail Pharmacies 9.3.5. Online Drug Stores 9.4. Market Attractiveness Analysis By Distribution Channel 10. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) and Analysis By Region, 2014 - 2018 10.3. Current Market Size (US$ Mn) and Analysis and Forecast By Region, 2019 - 2029 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. South Asia 10.3.5. East Asia 10.3.6. Oceania 10.3.7. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029 11.1. Introduction 11.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018 11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029 11.3.1. By Country 11.3.1.1. U.S. 11.3.1.2. Canada 11.3.2. By Drug Class 11.3.3. By Indication 11.3.4. By Distribution Channel 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Drug Class 11.4.3. By Indication 11.4.4. By Distribution Channel 11.5. Drivers and Restraints - Impact Analysis 12. Latin America Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029 12.1. Introduction 12.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018 12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Rest of Latin America 12.3.2. By Drug Class 12.3.3. By Indication 12.3.4. By Distribution Channel 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Drug Class 12.4.3. By Indication 12.4.4. By Distribution Channel 12.5. Drivers and Restraints - Impact Analysis 13. Europe Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029 13.1. Introduction 13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018 13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. Italy 13.3.1.3. France 13.3.1.4. U.K. 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Russia 13.3.1.8. Rest of Europe 13.3.2. By Drug Class 13.3.3. By Indication 13.3.4. By Distribution Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Drug Class 13.4.3. By Indication 13.4.4. By Distribution Channel 13.5. Drivers and Restraints - Impact Analysis 14. South Asia Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018 14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Indonesia 14.3.1.4. Malaysia 14.3.1.5. Rest of South Asia 14.3.2. By Drug Class 14.3.3. By Indication 14.3.4. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Drug Class 14.4.3. By Indication 14.4.4. By Distribution Channel 14.5. Drivers and Restraints - Impact Analysis 15. East Asia Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029 15.1. Introduction 15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018 15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.2. By Drug Class 15.3.3. By Indication 15.3.4. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Drug Class 15.4.3. By Indication 15.4.4. By Distribution Channel 15.5. Drivers and Restraints - Impact Analysis 16. Oceania Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018 16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Drug Class 16.3.3. By Indication 16.3.4. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Drug Class 16.4.3. By Indication 16.4.4. By Distribution Channel 16.5. Drivers and Restraints - Impact Analysis 17. Middle East and Africa Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018 17.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029 17.4.1. By Country 17.4.1.1. GCC Countries 17.4.1.2. Turkey 17.4.1.3. Northern Africa 17.4.1.4. South Africa 17.4.1.5. Rest of Middle East and Africa 17.4.2. By Drug Class 17.4.3. By Indication 17.4.4. By Distribution Channel 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Drug Class 17.5.3. By Indication 17.5.4. By Distribution Channel 17.6. Drivers and Restraints - Impact Analysis 18. Competition Analysis 18.1. Competition Dashboard 18.2. Competition Deep Dive 18.2.1. Bayer AG 18.2.1.1. Overview 18.2.1.2. Key Financials 18.2.1.3. Profitability by Market Segments (Product/Channel/Region) 18.2.1.4. Key Development 18.2.1.5. SWOT Analysis 18.2.1.6. Strategy Overview 18.2.1.6.1. Marketing Strategy 18.2.1.6.2. Product Strategy 18.2.1.6.3. Channel Strategy 18.2.2. GlaxoSmithKline Pharmaceuticals Ltd. 18.2.2.1. Overview 18.2.2.2. Key Financials 18.2.2.3. Profitability by Market Segments (Product/Channel/Region) 18.2.2.4. Key Development 18.2.2.5. SWOT Analysis 18.2.2.6. Strategy Overview 18.2.2.6.1. Marketing Strategy 18.2.2.6.2. Product Strategy 18.2.2.6.3. Channel Strategy 18.2.3. Pfizer 18.2.3.1. Overview 18.2.3.2. Key Financials 18.2.3.3. Profitability by Market Segments (Product/Channel/Region) 18.2.3.4. Key Development 18.2.3.5. SWOT Analysis 18.2.3.6. Strategy Overview 18.2.3.6.1. Marketing Strategy 18.2.3.6.2. Product Strategy 18.2.3.6.3. Channel Strategy 18.2.4. Allergan Plc 18.2.4.1. Overview 18.2.4.2. Key Financials 18.2.4.3. Profitability by Market Segments (Product/Channel/Region) 18.2.4.4. Key Development 18.2.4.5. SWOT Analysis 18.2.4.6. Strategy Overview 18.2.4.6.1. Marketing Strategy 18.2.4.6.2. Product Strategy 18.2.4.6.3. Channel Strategy 18.2.5. Almirall SA 18.2.5.1. Overview 18.2.5.2. Key Financials 18.2.5.3. Profitability by Market Segments (Product/Channel/Region) 18.2.5.4. Key Development 18.2.5.5. SWOT Analysis 18.2.5.6. Strategy Overview 18.2.5.6.1. Marketing Strategy 18.2.5.6.2. Product Strategy 18.2.5.6.3. Channel Strategy 18.2.6. Bristol-Myers Squibb 18.2.6.1. Overview 18.2.6.2. Key Financials 18.2.6.3. Profitability by Market Segments (Product/Channel/Region) 18.2.6.4. Key Development 18.2.6.5. SWOT Analysis 18.2.6.6. Strategy Overview 18.2.6.6.1. Marketing Strategy 18.2.6.6.2. Product Strategy 18.2.6.6.3. Channel Strategy 18.2.7. Merck & Co., Inc. 18.2.7.1. Overview 18.2.7.2. Key Financials 18.2.7.3. Profitability by Market Segments (Product/Channel/Region) 18.2.7.4. Key Development 18.2.7.5. SWOT Analysis 18.2.7.6. Strategy Overview 18.2.7.6.1. Marketing Strategy 18.2.7.6.2. Product Strategy 18.2.7.6.3. Channel Strategy 19. Assumptions and Acronyms Used 20. Research Methodology
Customize this Report
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 02: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 03: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel Table 04: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region Table 05: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country Table 06: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 07: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 08: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel Table 09: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country Table 10: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 11: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 12: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel Table 13: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country Table 14: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 15: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 16: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel Table 17: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country Table 18: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 19: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 20: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel Table 21: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country Table 22: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 23: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 24: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel Table 25: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country Table 26: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 27: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 28: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel Table 29: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country Table 30: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 31: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 32: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel Table 33: China Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 34: China Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 35: China Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel Table 36: India Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 37: India Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 38: India Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel Table 39: South Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class Table 40: South Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication Table 41: South Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018 Figure 02: Global Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029 Figure 03: Global Urinary Tract Infection Treatment Market Absolute $ Opportunity, 2019–2029 Figure 04: Global Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 05: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Drug Class, 2019 – 2029 Figure 06: Global Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 07: Global Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 08: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Indication, 2019 – 2029 Figure 09: Global Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 10: Global Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029 Figure 11: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2019 – 2029 Figure 12: Global Urinary Tract Infection Treatment Market Analysis by Distribution Channel –2019 & 2029 Figure 13: Global Urinary Tract Infection Treatment Market Analysis by Region–2019 & 2029 Figure 14: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Region, 2019 – 2029 Figure 15: Global Urinary Tract Infection Treatment Market Analysis by Region–2019 & 2029 Figure 16: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018 Figure 17: North America Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029 Figure 18: North America Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029 Figure 19: North America Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 20: North America Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 21: North America Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029 Figure 22: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018 Figure 23: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029 Figure 24: Latin America Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029 Figure 25: Latin America Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 26: Latin America Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 27: Latin America Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029 Figure 28: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018 Figure 29: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029 Figure 30: Europe Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029 Figure 31: Europe Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 32: Europe Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 33: Europe Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029 Figure 34: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018 Figure 35: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029 Figure 36: South Asia Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029 Figure 37: South Asia Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 38: South Asia Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 39: South Asia Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029 Figure 40: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018 Figure 41: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029 Figure 42: East Asia Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029 Figure 43: East Asia Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 44: East Asia Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 45: East Asia Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029 Figure 46: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018 Figure 47: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029 Figure 48: Oceania Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029 Figure 49: Oceania Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 50: Oceania Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 51: Oceania Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029 Figure 52: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018 Figure 53: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029 Figure 54: Middle East and Africa Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029 Figure 55: Middle East and Africa Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 56: Middle East and Africa Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 57: Middle East and Africa Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029 Figure 58: Emerging Countries Market Value Share (2019) Figure 59: Emerging Countries Urinary Tract Infection Treatment Market Value (US$ Mn), By Key Countries, 2019-2029 Figure 60: China Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 61: China Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 62: China Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029 Figure 63: India Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 64: India Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 65: India Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029 Figure 66: South Africa Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029 Figure 67: South Africa Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029 Figure 68: South Africa Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
